Jan Sieluk

Estimated Costs and Long-term Outcomes of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer Treated With Bacillus Calmette-Guérin in the Veterans Affairs Health System

Stephen B. Williams, Lauren E. Howard, Meagan Foster et al. · JAMA Network Open · 2021 · 62 citations · Full text

Medicine, Oncology, Urology +10

The Economic Burden of Recurrence in Triple-Negative Breast Cancer Among Working Age Patients in the United States

Jan Sieluk, Yan Song, Jonathan Freimark et al. · Advances in Therapy · 2021 · 21 citations

Medicine, Oncology, Pharmacoeconomics +17

Costs of Medical Care Among Augmentation Therapy Users and Non-Users with Alpha-1 Antitrypsin Deficiency in the United States

Jan Sieluk, Joseph Levy, Robert A. Sandhaus et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · 2018 · 18 citations · Full text

Pharmacy, Internal Medicine, Pharmacoeconomics +16

Real-World Treatment Patterns and Effectiveness Outcomes in Patients with Early-Stage Triple-Negative Breast Cancer

Amin Haiderali, Whitney Rhodes, Santosh Gautam et al. · Future Oncology · 2021 · 16 citations · Full text

Medicine, Oncology, Surgery +14

Medical costs of Alpha-1 antitrypsin deficiency-associated COPD in the United States

Jan Sieluk, Julia F. Slejko, Henry Silverman et al. · Orphanet Journal of Rare Diseases · 2020 · 11 citations · Full text

Pharmacy, Health Sciences, Pharmacoeconomics +17